Browse by: | Sort by: |
Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to Know
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
Kenneth Feingold, MD
University of California, San Francisco, San Francisco, CA
Available
Is HDL a Risk Factor or Risk Marker? The Clinical Take-Home Message
Jay Heinecke, MD
University of Washington Medical Center, Seattle, WA
Permission not
granted for presentation
granted for presentation
New Cholesterol Guidelines 2018
Neil J Stone, MD
Northwestern University, Chicago, IL
Available
Cholesterol-Carrying Lipoproteins and CVD Risk
Anne Carol Goldberg, MD
Washington Univ School of Med, Saint Louis, MO
Permission not
granted for presentation
granted for presentation
Residual Risk: How to Assess Risk beyond the ASCVD Risk Calculator
Marc-Andre Cornier, MD
University of Colorado School of Medicine, Aurora, CO
Available
Master Clinician: Management of Diabetes: Selecting Therapy Based on CVD Outcomes and Beyond
Carol H Wysham, MD
MultiCare Rockwood Clinic, Spokane, WA
Daniel J Drucker, MD
Mt Sinai Hospital, Toronto, ON
Jane E Reusch, MD
Rocky Mountain Regional VAMC, Aurora, CO
Hertzel C Gerstein, MD, MSc
McMaster University, Hamilton, ON
Coming soon
Pharmacotherapy for Lipid Disorders: Which Drugs for Which Disease
Robert Eckel, MD
University of Colorado Anschutz Medical Campus, Aurora, CO
Available
Outstanding Educator Award Presented to Kenneth Burman, MD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Available
Sidney H. Ingbar Award Presented to Carole Mendelson, PhD
Susan J Mandel, MD, MPH
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Available
Senescent cells: An Emerging Targetfor Diseases of Aging
Jan M van Deursen, PhD
Mayo Clinic, Rochester, MN
Coming soon
Targeting Cellular Senescence in Age-Related Osteoporosis and Frailty
Sundeep Khosla, MD
Mayo Clinic, Rochester, MN
Available
Applying Multi-omics in Adrenal Hypertension
Maria-Christina Zennaro, MD, PhD
INSERM, Paris, France
Available
The Expanding Spectrum of Primary Aldosteronism
Anand Vaidya, MD, MMSc
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Available
Looking for Cellular Origins of Primary Aldosteronism
Hironobu Sasano, MD, PhD
Tohoku University School of Medicine, Sendai, Japan
Permission not
granted for presentation
granted for presentation
Chylomicronemia: Is It Due to Genes or Environment or Both, and What Is the Contribution of Glycemic Control?
Alan Chait, MBChB, MD
University of Washington, Seattle, WA
Available
Triglycerides and ASCVD in Patients with Diabetes and Insulin Resistance: Evidence Connecting Them and the Most Likely Mechanisms
Ira J Goldberg, MD
NYU Medical Center, New York, NY
Available
Moderate Hypertriglyceridemia: Should It Be Treated, and If So, How?
P. Barton Duell, MD
Oregon Health and Science University, Portland, OR
Available
Using New and Emerging Therapies in Managing of Hypercholesterolemia
Ira Goldberg, MD
NYU Medical Center, New York, New York
Available
Risk Stratification: Coronary Calcium, ApoB, LDL Particle Size, Lp(a). Which Ones are Worthwhile and Why?
Ira Goldberg, MD
NYU Medical Center, New York, New York
Available
Diabetes and Heart Failure
Matthew Cavender, MD, MPH
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Available
Q&A/Panel Discussion
Matthew Cavender, MD, MPH
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Anders Carlson, MD
International Diabetes Center, Minneapolis, Minnesota
Mark Molitch, MD
Northwestern University, Chicago, Illinois
Available
What To Do when Your Patient has a High (or a Low) HDL
Jeffrey Barton Boord, MD,MPH
Parkview Health, Fort Wayne, IN
Available
Debate: The LDL Limbo. How Low Should You Go?
Alan Chait, MBBS, MD
Univ of WA, Seattle, WA
Steve Nissen, MD
Cleveland Clinic, Cleveland, OH
Henry N Ginsberg, MD
Columbia Univ College of Physicians and Surgeons, New York, NY
Available
Chair
Ira J Goldberg, M.D.
NYU Med Ctr, New York, NY
Available
Shared Mechanisms Linking Sugar-Regulated Carbohydrate and Lipid Metabolism
Mark A Herman, MD
Duke Univ Med Ctr, Durham, NC
Available